Illumina offices. Credit: Rick Starkman/Illumina European Commission's Illumina Antitrust Enforcement 'Misinterpreted' Regulation, Adviser to EU Top Court Says
An ECJ decision to follow its Advocate General's advice could doom the EU antitrust watchdog's other cases targeting mergers that don't meet revenue thresholds.
April 09, 2024 at 05:43 PM
3 minute read
Antitrust
U.S. biotech company Illumina has received some encouraging news in its fight against the European Commission's rejection of its approximately $8 billion acquisition of California blood-test startup Grail.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'Fire All the Bullets Now': EEOC Enforcements Surge
- 4'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
- 5Suspect in Courthouse Bombing Was Targeting Judge, Deputies, Say Prosecutors
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
